Shunsuke Ono

1.3k total citations
68 papers, 918 citations indexed

About

Shunsuke Ono is a scholar working on Economics and Econometrics, Pharmacology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Shunsuke Ono has authored 68 papers receiving a total of 918 indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Economics and Econometrics, 22 papers in Pharmacology and 14 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Shunsuke Ono's work include Health Systems, Economic Evaluations, Quality of Life (28 papers), Pharmaceutical Economics and Policy (21 papers) and Pharmacovigilance and Adverse Drug Reactions (12 papers). Shunsuke Ono is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (28 papers), Pharmaceutical Economics and Policy (21 papers) and Pharmacovigilance and Adverse Drug Reactions (12 papers). Shunsuke Ono collaborates with scholars based in Japan, United States and Taiwan. Shunsuke Ono's co-authors include Makiko Kusama, Yuichi Sugiyama, Yasuo Kodama, Hiroyuki Fukuda, Michael R. Vasko, Hirotaka Ono, Akio Fujimura, Yoshihiko Kadoya, Kazuto Yasuda and Mostafa Saidur Rahim Khan and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Shunsuke Ono

61 papers receiving 878 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shunsuke Ono Japan 17 278 154 112 110 109 68 918
Bennett Levitan United States 20 530 1.9× 119 0.8× 94 0.8× 90 0.8× 60 0.6× 80 1.3k
Tomas Salmonson Sweden 27 284 1.0× 121 0.8× 110 1.0× 449 4.1× 125 1.1× 60 1.7k
Beate Wieseler Germany 20 489 1.8× 203 1.3× 284 2.5× 139 1.3× 157 1.4× 36 1.5k
Sheryl L. Szeinbach United States 18 215 0.8× 73 0.5× 73 0.7× 66 0.6× 164 1.5× 66 1.2k
Rebecca J. Williams United States 8 367 1.3× 107 0.7× 495 4.4× 141 1.3× 122 1.1× 17 1.2k
Thomas J. Hwang United States 25 984 3.5× 146 0.9× 225 2.0× 201 1.8× 169 1.6× 94 2.1k
James P. Wilson United States 15 193 0.7× 111 0.7× 69 0.6× 90 0.8× 36 0.3× 31 1.2k
Nicholas C. Ide United States 11 316 1.1× 141 0.9× 414 3.7× 206 1.9× 60 0.6× 12 1.1k
Ameeta Parekh United States 10 99 0.4× 42 0.3× 178 1.6× 98 0.9× 38 0.3× 15 587
Bethan Hughes United Kingdom 12 93 0.3× 54 0.4× 90 0.8× 267 2.4× 53 0.5× 42 977

Countries citing papers authored by Shunsuke Ono

Since Specialization
Citations

This map shows the geographic impact of Shunsuke Ono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shunsuke Ono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shunsuke Ono more than expected).

Fields of papers citing papers by Shunsuke Ono

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shunsuke Ono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shunsuke Ono. The network helps show where Shunsuke Ono may publish in the future.

Co-authorship network of co-authors of Shunsuke Ono

This figure shows the co-authorship network connecting the top 25 collaborators of Shunsuke Ono. A scholar is included among the top collaborators of Shunsuke Ono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shunsuke Ono. Shunsuke Ono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ono, Shunsuke, et al.. (2025). Dose Determinations at Drug Approval Reviews: FDA‐Approved Drugs in Past 5 Years. Clinical Pharmacology & Therapeutics. 117(6). 1743–1753. 1 indexed citations
3.
Sato, Yuya & Shunsuke Ono. (2022). Regulatory Environment and Approvals in Cell and Gene Therapy Products Between Japan, the USA, and the EU. Therapeutic Innovation & Regulatory Science. 57(2). 227–237. 1 indexed citations
4.
Khan, Mostafa Saidur Rahim, et al.. (2021). Financial Literacy and Gambling Behavior in the United States. Journal of Gambling Studies. 38(2). 445–463. 19 indexed citations
5.
Ono, Shunsuke, et al.. (2021). Financial Literacy and Exercise Behavior: Evidence from Japan. Sustainability. 13(8). 4189–4189. 19 indexed citations
6.
Ito, Kyoko, et al.. (2021). Patient Preferences for Attributes of Chemotherapy for Lung Cancer: Discrete Choice Experiment Study in Japan. Frontiers in Pharmacology. 12. 697711–697711. 2 indexed citations
7.
Ono, Shunsuke, et al.. (2020). Quantitative Preferences for Lung Cancer Treatment from the Patients’ Perspective: A Systematic Review. Patient. 13(5). 521–536. 16 indexed citations
8.
Ono, Shunsuke, et al.. (2019). Analysis of Global Drug Development Pathways and Postmarketing Safety in Japan: Local Studies May Reduce Drug‐Related Deaths. Clinical and Translational Science. 12(4). 408–415. 5 indexed citations
9.
Ono, Shunsuke, et al.. (2017). Heterogeneity of Clinical Trials for Antihypertensive Drugs in Japan: Exploratory Analysis of Confirmatory Phase III Trials Used for Marketing Approval. Clinical Pharmacology & Therapeutics. 104(1). 120–129. 2 indexed citations
12.
Chang, Chia‐Hsien, et al.. (2013). Assessment of statin-associated muscle toxicity in Japan: a cohort study conducted using claims database and laboratory information. BMJ Open. 3(4). e002040–e002040. 34 indexed citations
13.
Yamada, Tōru, Yuka Watanabe, Makiko Kusama, Yuichi Sugiyama, & Shunsuke Ono. (2012). Factors associated with spontaneous reporting of adverse drug reactions in Japan. Pharmacoepidemiology and Drug Safety. 22(5). 468–476. 9 indexed citations
14.
Kusama, Makiko, et al.. (2011). Analysis of Labeling Decisions Regarding Therapeutic Indications During New Drug Application Reviews in Japan. Clinical Pharmacology & Therapeutics. 90(3). 432–441. 1 indexed citations
15.
Saito, Kazuyuki, Yasuo Kodama, Shunsuke Ono, & Akio Fujimura. (2010). Characteristics of Clinical Trials Conducted in Japan under the New GCP Guideline: Analysis of PMDA Audit Reports. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 41(5). 253–257. 2 indexed citations
16.
Ono, Shunsuke, et al.. (2006). Cost-Effectiveness Analysis of Antiretroviral Drug Treatment and HIV-1 Vaccination in Thailand. Japanese Journal of Infectious Diseases. 59(3). 168–173. 14 indexed citations
17.
Naruhashi, Kazumasa, Masaaki Nomura, Hiroyuki Kamei, et al.. (2003). Objective Evaluation of Clinical Pharmacy Lectures and Experience in a Master Program Using Visual Analog Scale Method. YAKUGAKU ZASSHI. 123(11). 973–980. 14 indexed citations
18.
Ono, Shunsuke, Yasuo Kodama, Taku Nagao, & Satoshi Toyoshima. (2002). The quality of conduct in Japanese clinical trials. Controlled Clinical Trials. 23(1). 29–41. 16 indexed citations
19.
Ono, Shunsuke & Yasuo Kodama. (2000). Clinical Trials and the New Good Clinical Practice Guideline in Japan. PharmacoEconomics. 18(2). 125–141. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026